"THE ONE RING" AND EOSINOPHILIC ESOPHAGITIS AS TRICKY TRIGGERS OF REFLUX SYMPTOMS – A CASE REPORT AND LITERATURE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(47).2025.3639Keywords:
Eosinophilic Esophagitis, Schatzki Ring, DysphagiaAbstract
Background: eosinophilic esophagitis (EoE) and Schatzki ring are distinct conditions, but their clinical presentation may resemble one another. Moreover, they can closely mimic the third common disorder, that is gastroesophageal reflux disease (GERD) making a patient diagnostic approach even more challenging.
Aim of the study: presentation of a case with EoE with coexistence of Schatzki ring and related subject literature review.
Materials and methods: one case of non-specific GERD symptoms and gradual dysphagia development. Literature review of existing reports and data regarding epidemiology, clinical presentation, and diagnostic approach to patients with EoE suspicion. Presentation of the current guidelines on disease management. Additionally, we discuss the medical challenges that may occur in patients with esophageal dysfunction and highlight that further studies are warranted to better explain EoE's long-term impact on patient outcomes.
Conclusions: EoE has become increasingly recognized over the last decade, but may still create a clinical challenge. Its symptoms vary with age, and pathogenesis is still not fully explained. Experts in the field recommend special criteria for diagnosing EoE, which should be followed to establish the proper diagnosis. Further studies are warranted to better explain EoE's pathophysiology and long-term impact on patient outcomes.
References
Gonsalves NP, Aceves SS. Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2020 Jan;145(1):1-7. doi: 10.1016/j.jaci.2019.11.011. PMID: 31910983; PMCID: PMC6986782
Watts LD, Patel K. Schatzki Ring(Archived) - PubMed. 2023 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30085564
Pfefferlé M, Greuter T. An algorithm for the diagnosis and treatment of eosinophilic esophagitis in adults, 2024 update. Allergy. 2024 Dec;79(12):3546-3549. doi: 10.1111/all.16279. Epub 2024 Aug 21. PMID: 39166414
Dellon, Evan S. MD, MPH, FACG1; Muir, Amanda B. MD2,3,4; Katzka, David A. MD, FACG5; Shah, Shailja C. MD, MPH6,7; Sauer, Bryan G. MD, MSc, FACG8; Aceves, Seema S. MD, PhD9,10; Furuta, Glenn T. MD11,12; Gonsalves, Nirmala MD, FACG13,*; Hirano, Ikuo MD, FACG13,*,†. ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis. The American Journal of Gastroenterology 120(1):p 31-59, January 2025. DOI: 10.14309/ajg.0000000000003194.
Lucendo AJ. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Rev Clin Immunol. 2020 Jan;16(1):63-77. doi: 10.1080/1744666X.2019.1705784. Epub 2020 Jan 6. PMID: 31842634
Tamarit-Sebastian S, Ferrer-Soler FM, Lucendo AJ. Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opin Investig Drugs. 2022 Feb;31(2):193-210. doi: 10.1080/13543784.2022.2033207. Epub 2022 Jan 31. PMID: 35072575
Navarro P, Laserna-Mendieta EJ, Guagnozzi D, Casabona S, Perelló A, Savarino E, de la Riva S, Olalla JM, Ghisa M, Serrano-Moya N, Alcolea-Valero C, Ortega-Rabbione G, Majano P, Santander C, Arias Á, Lucendo AJ; EUREOS EoE CONNECT research group. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis. Dig Liver Dis. 2021 Nov;53(11):1479-1485. doi: 10.1016/j.dld.2021.05.025. Epub 2021 Jun 10. PMID: 34120859
Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang JC. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010 May;55(5):1313-9. doi: 10.1007/s10620-009-0859-4. Epub 2009 Jun 18. PMID: 19533356
Hahn JW, Lee K, Shin JI, Cho SH, Turner S, Shin JU, Yeniova AÖ, Koyanagi A, Jacob L, Smith L, Fond G, Boyer L, Lee SW, Kwon R, Kim S, Shin YH, Rhee SY, Moon JS, Ko JS, Yon DK, Papadopoulos NG. Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976-2022: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3270-3284.e77. doi: 10.1016/j.cgh.2023.06.005. Epub 2023 Jun 17. PMID: 37331411
Amil-Dias J, Oliva S, Papadopoulou A, Thomson M, Gutiérrez-Junquera C, Kalach N, Orel R, Auth MK, Nijenhuis-Hendriks D, Strisciuglio C, Bauraind O, Chong S, Ortega GD, Férnandez SF, Furman M, Garcia-Puig R, Gottrand F, Homan M, Huysentruyt K, Kostovski A, Otte S, Rea F, Roma E, Romano C, Tzivinikos C, Urbonas V, Velde SV, Zangen T, Zevit N. Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2024 Aug;79(2):394-437. doi: 10.1002/jpn3.12188. Epub 2024 Jun 24. PMID: 38923067)
Vincenzo Savarino E, Fassan M, de Bortoli N, Romano C, Di Sabatino A, Penagini R, Racca F, Sarnelli G, Oliva S. Italian EoExpert panel recommendation for disease control, switching criteria, and follow-up in eosinophilic esophagitis from pediatric to adult age. Therap Adv Gastroenterol. 2025 May 8;18:17562848251337515. doi: 10.1177/17562848251337515 PMID: 40351381; PMCID: PMC12062651
Molina-Infante J, Arias Á, Alcedo J, Garcia-Romero R, Casabona-Frances S, Prieto-Garcia A, Modolell I, Gonzalez-Cordero PL, Perez-Martinez I, Martin-Lorente JL, Guarner-Argente C, Masiques ML, Vila-Miravet V, Garcia-Puig R, Savarino E, Sanchez-Vegazo CT, Santander C, Lucendo AJ. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. J Allergy Clin Immunol. 2018 Apr;141(4):1365-1372. doi: 10.1016/j.jaci.2017.08.038. Epub 2017 Oct 23. PMID: 29074457
Uchida AM, Burk CM, Rothenberg ME, Furuta GT, Spergel JM. Recent Advances in the Treatment of Eosinophilic Esophagitis. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2654-2663. doi: 10.1016/j.jaip.2023.06.035. Epub 2023 Jun 28. PMID: 37391018; PMCID: PMC10530275; Massironi S, Mulinacci G, Gallo C, Elvevi A, Danese S, Invernizzi P, Vespa E. Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms. Cells. 2023 Oct 18;12(20):2473. doi: 10.3390/cells12202473. PMID: 37887317; PMCID: PMC10605530
Ridolo E, Barone A, Ottoni M, Peveri S, Montagni M, Nicoletta F. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs. Int J Mol Sci. 2024 Jan 30;25(3):1702. doi: 10.3390/ijms25031702. PMID: 38338983; PMCID: PMC10855546
Dellon ES, Gupta SK. A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2149-2160. doi: 10.1016/j.cgh.2019.01.030. Epub 2019 Jan 30. PMID: 30710696; PMCID: PMC6667323
Beveridge CA, Hermanns C, Thanawala S, Chatterjee A, Sharma N, Vura NVRK, Yang Q, Qin Y, Thota P, Hoscheit M, Brown JM, Ivanov AI, Lembo A, Gabbard S, Rieder F. Predictors of persistent symptoms in eosinophilic esophagitis after remission: fibrostenosis, eosinophilia, anxiety, and depression. Dis Esophagus. 2025 Jan 7;38(1):doae110. doi: 10.1093/dote/doae110. PMID: 39673363).
Zhou MJ, Hsing AW, Clarke JO. Prevalence and predictors of Barrett's esophagus and esophageal cancer in patients with eosinophilic esophagitis. Dis Esophagus. 2025 Jan 7;38(1):doae120. doi: 10.1093/dote/doae120. PMID: 39775829
Jalil S, Castell DO. Schatzki's ring: a benign cause of dysphagia in adults. J Clin Gastroenterol. 2002 Oct;35(4):295-8. doi: 10.1097/00004836-200210000-00004. PMID: 12352291
Smith MS. Diagnosis and management of esophageal rings and webs. Gastroenterol Hepatol (N Y). 2010 Nov;6(11):701-4. PMID: 21437018; PMCID: PMC3033540; https://pmc.ncbi.nlm.nih.gov/articles/PMC3033540/
Sarbinowska J, Wiatrak B, Waśko-Czopnik D. Esophageal Motility Disorders in the Natural History of Acid-Dependent Causes of Dysphagia and Their Influence on Patients' Quality of Life-A Prospective Cohort Study. Int J Environ Res Public Health. 2021 Oct 23;18(21):11138. doi: 10.3390/ijerph182111138. PMID: 34769657; PMCID: PMC8583542
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

